Plexus (PLXS) insider OLIVER plans sale of 2,226 common shares

Rhea-AI Filing Summary

Plexus Corp. insider OLIVER has filed a Form 144 indicating an intention to sell 2,226 shares of common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 02/17/2026 and an aggregate market value of 442,495.41.

The 2,226 shares were acquired on 02/11/2025 as performance shares directly from the issuer. Plexus had 26,786,466 shares outstanding at the time referenced. In the past three months, OLIVER also sold 2,327 common shares on 11/25/2025 for gross proceeds of 333,179.86.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2226	442495.41	26786466	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2025	Performance Shares	Issuer			2226	02/11/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
OLIVER MIHM One Plexus Way Neenah WI 54956	Common	11/25/2025	2327	333179.86

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PLXS Form 144 filing by OLIVER disclose?

The Form 144 discloses OLIVER’s planned sale of Plexus shares. OLIVER intends to sell 2,226 common shares of Plexus, acquired as performance shares, with an aggregate market value of 442,495.41, through Morgan Stanley Smith Barney LLC on NASDAQ around 02/17/2026.

How many Plexus (PLXS) shares is OLIVER planning to sell under Form 144?

OLIVER plans to sell 2,226 Plexus common shares. These shares were acquired on 02/11/2025 as performance shares from the issuer, and the planned transaction has an aggregate market value of 442,495.41 based on the figures disclosed in the notice.

What prior Plexus (PLXS) share sales by OLIVER are disclosed in the Form 144?

The filing reports a prior sale of 2,327 Plexus shares. On 11/25/2025, OLIVER sold 2,327 common shares for gross proceeds of 333,179.86, and this transaction is listed as activity within the past three months.

How many Plexus (PLXS) shares were outstanding according to the Form 144?

The Form 144 lists 26,786,466 Plexus shares outstanding. This outstanding share figure provides context for OLIVER’s planned sale of 2,226 common shares and the previously reported sale of 2,327 shares during the last three months.